Publications

Latest

16 Jun 2021

Activity Report 2020

GARDP continued to make progress in 2020 despite the challenges of the COVID-19 pandemic. The Activity Report 2020 showcases the work of GARDP to develop treatments for the drug-resistant infections posing the greatest threat to health, and to ensure these treatments are responsibly available for all who need them. Available in English | Deutsch | Français.

All

Horizon scanning for antibacterial drug discovery projects focused on WHO critical priority Gram-negative bacterial pathogens

A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution

Shortage of essential antimicrobials: a major challenge to global health security

NIMble innovation—a networked model for public antibiotic trials

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug‑Resistant Bacteria

Towards the sustainable discovery and development of new antibiotics

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.